$4000 | Single User
$8000 | Site License
$12000 | Enterprise License

Artificial Pancreas - Medical Devices Pipeline Assessment, 2016
[Published by Global Data]

Published by Global Data: 11 Mar 2016 | 18198 | In Stock
Related Topics: Medical Devices

Introduction

Artificial Pancreas - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, “Artificial Pancreas - Medical Devices Pipeline Assessment, 2016" provides an overview of Artificial Pancreas currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Artificial Pancreas pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Artificial Pancreas under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Artificial Pancreas and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to -

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Artificial Pancreas under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents
for Artificial Pancreas - Medical Devices Pipeline Assessment, 2016 [Published by Global Data]

  • 1 Table of Contents

    1 Table of Contents 2

    1.1 List of Tables 5

    1.2 List of Figures 8

    2 Introduction 9

    2.1 Artificial Pancreas Overview 9

    3 Products under Development 10

    3.1 Artificial Pancreas - Pipeline Products by Stage of Development 10

    3.2 Artificial Pancreas - Pipeline Products by Territory 11

    3.3 Artificial Pancreas - Pipeline Products by Regulatory Path 12

    3.4 Artificial Pancreas - Pipeline Products by Estimated Approval Date 13

    3.5 Artificial Pancreas - Ongoing Clinical Trials 14

    4 Artificial Pancreas - Pipeline Products under Development by Companies 15

    4.1 Artificial Pancreas Companies - Pipeline Products by Stage of Development 15

    4.2 Artificial Pancreas - Pipeline Products by Stage of Development 17

    5 Artificial Pancreas Companies and Product Overview 19

    5.1 Admetsys Corporation Company Overview 19

    5.1.1 Admetsys Corporation Pipeline Products & Ongoing Clinical Trials Overview 19

    5.2 Advanced Biosensors-Ohio, Llc Company Overview 20

    5.2.1 Advanced Biosensors-Ohio, Llc Pipeline Products & Ongoing Clinical Trials Overview 20

    5.3 Animas Corporation Company Overview 21

    5.3.1 Animas Corporation Pipeline Products & Ongoing Clinical Trials Overview 21

    5.4 Beta-O2 Technologies Ltd. Company Overview 22

    5.4.1 Beta-O2 Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 22

    5.5 Bigfoot Biomedical, Inc. Company Overview 26

    5.5.1 Bigfoot Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26

    5.6 BioTex, Inc. Company Overview 27

    5.6.1 BioTex, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27

    5.7 Boston University Company Overview 28

    5.7.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 28

    5.8 Cerco Medical LLC Company Overview 29

    5.8.1 Cerco Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 29

    5.9 Converge Biotech, Inc. Company Overview 30

    5.9.1 Converge Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30

    5.10 Covalor Medical, LLC Company Overview 31

    5.10.1 Covalor Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 31

    5.11 De Montfort University Company Overview 32

    5.11.1 De Montfort University Pipeline Products & Ongoing Clinical Trials Overview 32

    5.12 Debiotech S.A. Company Overview 33

    5.12.1 Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview 33

    5.13 Defymed, Inc. Company Overview 34

    5.13.1 Defymed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34

    5.14 Diabeloop Company Overview 36

    5.14.1 Diabeloop Pipeline Products & Ongoing Clinical Trials Overview 36

    5.15 Giner, Inc. Company Overview 39

    5.15.1 Giner, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39

    5.16 Imperial College London Company Overview 41

    5.16.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 41

    5.17 Inreda Diabetic BV Company Overview 46

    5.17.1 Inreda Diabetic BV Pipeline Products & Ongoing Clinical Trials Overview 46

    5.18 Kencak LLC Company Overview 47

    5.18.1 Kencak LLC Pipeline Products & Ongoing Clinical Trials Overview 47

    5.19 Medtronic plc Company Overview 48

    5.19.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 48

    5.20 Miromatrix Medical Inc. Company Overview 56

    5.20.1 Miromatrix Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 56

    5.21 Pacific Diabetes Technologies, Inc. Company Overview 58

    5.21.1 Pacific Diabetes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 58

    5.22 Pancreum, LLC Company Overview 59

    5.22.1 Pancreum, LLC Pipeline Products & Ongoing Clinical Trials Overview 59

    5.23 PharmaCyte Biotech, Inc. Company Overview 61

    5.23.1 PharmaCyte Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61

    5.24 Rensselaer Polytechnic Institute Company Overview 63

    5.24.1 Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 63

    5.25 Schneider Children's Medical Center of Israel Company Overview 65

    5.25.1 Schneider Children's Medical Center of Israel Pipeline Products & Ongoing Clinical Trials Overview 65

    5.26 TecMed, Inc. Company Overview 69

    5.26.1 TecMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 69

    5.27 The University of Newcastle Company Overview 70

    5.27.1 The University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview 70

    5.28 TypeZero Technologies LLC Company Overview 71

    5.28.1 TypeZero Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 71

    5.29 Ultradian Diagnostics LLC Company Overview 75

    5.29.1 Ultradian Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 75

    5.30 Universidad Autonoma de Madrid Company Overview 76

    5.30.1 Universidad Autonoma de Madrid Pipeline Products & Ongoing Clinical Trials Overview 76

    5.31 Universitat Politecnica de Valencia Company Overview 77

    5.31.1 Universitat Politecnica de Valencia Pipeline Products & Ongoing Clinical Trials Overview 77

    5.32 University of California, San Francisco Company Overview 78

    5.32.1 University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview 78

    5.33 University of California, Santa Barbara Company Overview 79

    5.33.1 University of California, Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview 79

    5.34 University of Cambridge Company Overview 82

    5.34.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 82

    5.35 University of Florida Company Overview 84

    5.35.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 84

    5.36 XERIS Pharmaceuticals, Inc. Company Overview 85

    5.36.1 XERIS Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 85

    6 Artificial Pancreas - Recent Developments 86

    7 Appendix 95

    7.1 Methodology 95

    7.2 About GlobalData 97

    7.3 Contact Us 98

    7.4 Disclaimer 98

List Of Tables
in Artificial Pancreas - Medical Devices Pipeline Assessment, 2016 [Published by Global Data]

1.1 List of Tables

Table 1: Artificial Pancreas - Pipeline Products by Stage of Development 10

Table 2: Artificial Pancreas - Pipeline Products by Territory 11

Table 3: Artificial Pancreas - Pipeline Products by Regulatory Path 12

Table 4: Artificial Pancreas - Pipeline Products by Estimated Approval Date 13

Table 5: Artificial Pancreas - Ongoing Clinical Trials 14

Table 6: Artificial Pancreas Companies - Pipeline Products by Stage of Development 15

Table 7: Artificial Pancreas - Pipeline Products by Stage of Development 17

Table 8: Admetsys Corporation Pipeline Products & Ongoing Clinical Trials Overview 19

Table 9: Admetsys Smart Pancreas - Product Status 19

Table 10: Admetsys Smart Pancreas - Product Description 19

Table 11: Advanced Biosensors-Ohio, Llc Pipeline Products & Ongoing Clinical Trials Overview 20

Table 12: Artificial Pancreas - Product Status 20

Table 13: Artificial Pancreas - Product Description 20

Table 14: Animas Corporation Pipeline Products & Ongoing Clinical Trials Overview 21

Table 15: Hypoglycemia-Hyperglycemia Minimizer System - Product Status 21

Table 16: Hypoglycemia-Hyperglycemia Minimizer System - Product Description 21

Table 17: Beta-O2 Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 22

Table 18: ßAir Bio-artificial Pancreas - Product Status 23

Table 19: ßAir Bio-artificial Pancreas - Product Description 23

Table 20: Beta-O2 Technologies Ltd. - Ongoing Clinical Trials Overview 24

Table 21: ßAir Bio-artificial Pancreas - An Open Label, Pilot Investigation, to Assess the Safety and Efficacy of Transplantation of Macro-encapsulated Human Islets within the Bioartificial Pancreas Beta-Air in Patients with Type 1 Diabetes Mellitus 25

Table 22: Bigfoot Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26

Table 23: Artificial Pancreas - Product Status 26

Table 24: Artificial Pancreas - Product Description 26

Table 25: BioTex, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27

Table 26: Artificial Pancreas - Product Status 27

Table 27: Artificial Pancreas - Product Description 27

Table 28: Boston University Pipeline Products & Ongoing Clinical Trials Overview 28

Table 29: iLet - Product Status 28

Table 30: iLet - Product Description 28

Table 31: Cerco Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 29

Table 32: Islet Sheet - Product Status 29

Table 33: Islet Sheet - Product Description 29

Table 34: Converge Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30

Table 35: Bioartificial Pancreas System - Product Status 30

Table 36: Bioartificial Pancreas System - Product Description 30

Table 37: Covalor Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 31

Table 38: Artificial Pancreas - Product Status 31

Table 39: Artificial Pancreas - Product Description 31

Table 40: De Montfort University Pipeline Products & Ongoing Clinical Trials Overview 32

Table 41: InSmart Artificial Pancreas - Product Status 32

Table 42: InSmart Artificial Pancreas - Product Description 32

Table 43: Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview 33

Table 44: Next Generation Artificial Pancreas - Product Status 33

Table 45: Next Generation Artificial Pancreas - Product Description 33

Table 46: Defymed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34

Table 47: MAILPAN - Product Status 35

Table 48: MAILPAN - Product Description 35

Table 49: Diabeloop Pipeline Products & Ongoing Clinical Trials Overview 36

Table 50: Diabeloop - Product Status 36

Table 51: Diabeloop - Product Description 36

Table 52: Diabeloop - Ongoing Clinical Trials Overview 37

Table 53: Diabeloop - Crossover Evaluation of Glycemic Control Provided for Three Days by the Artificial Pancreas Diabeloop Compared to Conventional Treatment by External Insulin Pump in Patients with Type 1 Diabetes in Sedentary Position, Outstanding Meals and Physical Activity: DIABELOOP WP6.2 38

Table 54: Giner, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39

Table 55: BAPIOS System - Product Status 40

Table 56: BAPIOS System - Product Description 40

Table 57: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 41

Table 58: Bio-inspired Artificial Pancreas - Product Status 42

Table 59: Bio-inspired Artificial Pancreas - Product Description 42

Table 60: Imperial College London - Ongoing Clinical Trials Overview 43

Table 61: Bio-inspired Artificial Pancreas - A Multicenter Study of Outpatient Automated Blood Glucose Control With a Bihormonal Bionic Pancreas 44

Table 62: Bio-inspired Artificial Pancreas - Closed-Loop Glucagon Administration for the Automated Prevention and Treatment of Hypoglycemia 44

Table 63: Bio-inspired Artificial Pancreas - The Summer Camp Study 2: Outpatient Automated Blood Glucose Control With a Bi-Hormonal Bionic Endocrine Pancreas in a Pediatric Population Ages 6-11 at the Clara Barton Diabetes Camps 45

Table 64: Inreda Diabetic BV Pipeline Products & Ongoing Clinical Trials Overview 46

Table 65: Bi-Hormonal Artificial Pancreas - Product Status 46

Table 66: Bi-Hormonal Artificial Pancreas - Product Description 46

Table 67: Kencak LLC Pipeline Products & Ongoing Clinical Trials Overview 47

Table 68: BioArtificial Pancreas - Product Status 47

Table 69: BioArtificial Pancreas - Product Description 47

Table 70: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 48

Table 71: Hybrid Closed Loop System - Product Status 49

Table 72: Hybrid Closed Loop System - Product Description 49

Table 73: MiniMed 640G System - Product Status 50

Table 74: MiniMed 640G System - Product Description 50

Table 75: Third-Generation Artificial Pancreas System - Product Status 51

Table 76: Third-Generation Artificial Pancreas System - Product Description 51

Table 77: Medtronic plc - Ongoing Clinical Trials Overview 52

Table 78: Hybrid Closed Loop System - Feasibility Study to Evaluate the Hybrid-logic Closed Loop System in Type 1 Diabetes -Single-arm, Single-center, in Clinic Study-The DREMED Trial 53

Table 79: Hybrid Closed Loop System - Preventing Hypoglycemia During Exercise With Proactive Snacking on Closed Loop 53

Table 80: MiniMed 640G System - A Performance Evaluation of the Enlite 3 Sensor 54

Table 81: MiniMed 640G System - Prevention of Hypoglycaemia Using the Minimed 640G System 54

Table 82: MiniMed 640G System - Standardized Evaluation of Subcutaneous Glucose Monitoring Systems under Routine Environmental Conditions 55

Table 83: MiniMed 640G System - Study of Minimed 640G Insulin Pump with SmartGuard in Prevention of Low Glucose Events in Adults with Type 1 Diabetes at Risk of Severe Hypoglycemia 55

Table 84: Miromatrix Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 56

Table 85: Miro Pancreas - Product Status 57

Table 86: Miro Pancreas - Product Description 57

Table 87: Pacific Diabetes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 58

Table 88: Single Indicating electrode Sensing Catheter - Product Status 58

Table 89: Single Indicating electrode Sensing Catheter - Product Description 58

Table 90: Pancreum, LLC Pipeline Products & Ongoing Clinical Trials Overview 59

Table 91: Genesis Artificial Pancreas - Product Status 60

Table 92: Genesis Artificial Pancreas - Product Description 60

Table 93: PharmaCyte Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61

Table 94: Bio-Artificial Pancreas - Product Status 62

Table 95: Bio-Artificial Pancreas - Product Description 62

Table 96: Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 63

Table 97: Closed-Loop Artificial Pancreas System - Product Status 64

Table 98: Closed-Loop Artificial Pancreas System - Product Description 64

Table 99: Schneider Children's Medical Center of Israel Pipeline Products & Ongoing Clinical Trials Overview 65

Table 100: MD-Logic Artificial Pancreas - Product Status 66

Table 101: MD-Logic Artificial Pancreas - Product Description 66

Table 102: Schneider Children's Medical Center of Israel - Ongoing Clinical Trials Overview 67

Table 103: MD-Logic Artificial Pancreas - Open-label, 3 Center, Randomized, Cross-over Study to Evaluate the Safety and Efficacy of 60 Hours Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy at T1D Patients at Home 68

Table 104: TecMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 69

Table 105: TecMed Artificial Pancreas - Product Status 69

Table 106: TecMed Artificial Pancreas - Product Description 69

Table 107: The University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview 70

Table 108: Closed Glucose-Sensing Insulin-Delivery System - Product Status 70

Table 109: Closed Glucose-Sensing Insulin-Delivery System - Product Description 70

Table 110: TypeZero Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 71

Table 111: inControl AP - Product Status 71

Table 112: inControl AP - Product Description 71

Table 113: TypeZero Technologies LLC - Ongoing Clinical Trials Overview 72

Table 114: inControl AP - A Trial on Artificial Pancreas to Manage Type 1 diabetes By Automatically Regulating Insulin and Blood Sugar Levels 73

Table 115: inControl AP - Examination of New Control Algorithm of inControl AP 73

Table 116: inControl AP - International Diabetes Closed Loop Trial ("IDCL") 74

Table 117: Ultradian Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 75

Table 118: Artificial Pancreas - Product Status 75

Table 119: Artificial Pancreas - Product Description 75

Table 120: Universidad Autonoma de Madrid Pipeline Products & Ongoing Clinical Trials Overview 76

Table 121: Predictive Rule-Based Algorithm - Product Status 76

Table 122: Predictive Rule-Based Algorithm - Product Description 76

Table 123: Universitat Politecnica de Valencia Pipeline Products & Ongoing Clinical Trials Overview 77

Table 124: ClosedLoop 4Meal Control - Product Status 77

Table 125: ClosedLoop 4Meal Control - Product Description 77

Table 126: University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview 78

Table 127: Bioartificial Pancreas - Product Status 78

Table 128: Bioartificial Pancreas - Product Description 78

Table 129: University of California, Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview 79

Table 130: Closed-Loop Artificial Pancreas - Product Status 80

Table 131: Closed-Loop Artificial Pancreas - Product Description 80

Table 132: Pediatric Artificial Pancreas - Product Status 81

Table 133: Pediatric Artificial Pancreas - Product Description 81

Table 134: University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 82

Table 135: Florence D2A System - Product Status 83

Table 136: Florence D2A System - Product Description 83

Table 137: University of Florida Pipeline Products & Ongoing Clinical Trials Overview 84

Table 138: Bioartificial Pancreas - Type 1 Diabetes - Product Status 84

Table 139: Bioartificial Pancreas - Type 1 Diabetes - Product Description 84

Table 140: XERIS Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 85

Table 141: G-Pump - BP - Product Status 85

Table 142: G-Pump - BP - Product Description 85

Table 143: Glossary 96

List Of Figures, Charts and Diagrams
in Artificial Pancreas - Medical Devices Pipeline Assessment, 2016 [Published by Global Data]

1.2 List of Figures

Figure 1: Artificial Pancreas - Pipeline Products by Stage of Development 10

Figure 2: Artificial Pancreas - Pipeline Products by Territory 11

Figure 3: Artificial Pancreas - Pipeline Products by Regulatory Path 12

Figure 4: Artificial Pancreas - Pipeline Products by Estimated Approval Date 13

Figure 5: Artificial Pancreas - Ongoing Clinical Trials 14

Additional Details

Publisher

Global Data

Publisher Information

Reference

18198 | GDME0156EPD

Number of Pages

98

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Sugar-Based Excipients Market by Product (Actual Sugars, Sugar Alcohols, Artificial Sweeteners), Type (Powder/Granule, Crystal, Syrup), Functionality (Filler & Diluent, Tonicity Agents), Formulation (Oral, Topical, Parenteral) - Global Forecast to 2021
The global sugar excipients market is estimated to grow at a CAGR of 4.3% from 2016 to 2021, to reac...
08 Dec 2016 by MarketsandMarkets USD $5,650 More Info
Total Artificial Heart - Medical Devices Pipeline Assessment, 2016
Total Artificial Heart - Medical Devices Pipeline Assessment, 2016SummaryGlobalData's Medical Device...
01 Jun 2016 by Global Data USD $2,500 More Info
Total Artificial Heart - Medical Devices Pipeline Assessment, 2016
Total Artificial Heart - Medical Devices Pipeline Assessment, 2016SummaryGlobalData's Medical Device...
01 Jun 2016 by Global Data USD $2,500 More Info
Artificial Disc Replacement Systems - Medical Devices Pipeline Assessment, 2016
Artificial Disc Replacement Systems - Medical Devices Pipeline Assessment, 2016SummaryGlobalData's M...
11 Mar 2016 by Global Data USD $4,000 More Info
North America Unsaturated Polyester Resin Market By Type, By Application (Building & Construction, Marine, Automotive & Transportation, Pipes & Tanks, Electrical & Electronics, Wind Energy, Artificial Stones), By Geography– Analysis & Forecast to 2020
Unsaturated polyester resins (UPR) are highly durable, when they are cross linked with monomers such...
01 Oct 2015 by MicroMarketMonitor USD $2,650 More Info
Europe Well Intervention Services Market by Service Types (Logging & Bottom Hole Survey, Tubing/Packer Failure & Repair, Stimulation, Artificial Lift, Others), by Application (Onshore & Offshore), and by Geographies – Analysis & Forecast to 2019
In Europe Well Intervention Services Market report, well intervention market is segmented on the bas...
18 May 2015 by MarketsandMarkets USD $2,650 More Info
Middle East Well Intervention Market by Service Type (Logging & Bottom Hole Survey, Tubing/Packer Failure & Repair, Stimulation, Artificial Lift, Others), Application (Onshore & Offshore), & Country - Analysis & Forecast to 2019
Well intervention services are required throughout the lifespan of an oil & gas well. Worldwide incr...
13 May 2015 by MarketsandMarkets USD $2,650 More Info
Asia Pacific Well Intervention Market by Service Type (Logging & Bottom Hole Survey, Tubing/Packer Failure & Repair, Stimulation, Artificial Lift, Others), by Application (Onshore & Offshore), and by Country - Analysis & Forecast To 2019
Asia-Pacific well intervention services market is estimated to grow at a CAGR of 3.5% from 2014 to 2...
07 May 2015 by MarketsandMarkets USD $2,650 More Info
North America Well Intervention Market by Service Types (Logging & Bottom Hole Survey, Tubing/Packer Failure & Repair, Stimulation, Artificial Lift, Others), By Application (Onshore & Offshore), and By Countries – Analysis & Forecast to 2019
The North America well intervention market constitutes 50% of the global Well Intervention market, a...
02 May 2015 by MarketsandMarkets USD $2,650 More Info
Africa Well Intervention Service Market by Types (Logging & Bottom Hole Survey, Tubing/Packer Failure & Repair, Stimulation, Artificial Lift, Others), by Application (Onshore & Offshore), and by Countries - Analysis and Forecast to 2019
The well intervention services market is estimated to grow at a CAGR of 4% from 2014 to 2019. Geogra...
28 Apr 2015 by MarketsandMarkets USD $2,650 More Info

This report is published by Global Data

Download Free Report Summary PDF

Artificial Pancreas - Medical Devices Pipeline Assessment, 2016 [Published by Global Data] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...